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Right Atrial Pressure: Can It Be Ignored When Calculating
Fractional Flow Reserve and Collateral Flow Index?
To the Editor: Intracoronary pressure measurements are increas-
ingly used to assess the physiologic significance of epicardial
coronary stenoses, particularly when the angiographic severity is
considered equivocal. Myocardial fractional flow reserve (FFR)
expresses the maximum myocardial flow achievable in the presence
of an epicardial stenosis in relation to the theoretical maximum
flow without the obstruction and is calculated by simultaneous
measurement of mean aortic (Pa), right atrial (Pra), and distal
coronary pressure (Pd) (1): FFR  (Pd  Pra)/(Pa  Pra). In
patients with intermediate coronary lesions, without evidence of
reversible ischemia, a FFR below 0.75 can be used to identify
patients who would benefit from a percutaneous coronary inter-
vention (PCI) (2).
An analogous index is the pressure-derived collateral flow index
(CFI), which can be used to quantify the relative contribution of
collateral flow to myocardial perfusion. CFI (Pw Pra)/(Pa Pra),
where Pw is coronary wedge pressure measured during transient
coronary occlusion by balloon inflation (3). A CFI 0.25 is usually
associated with myocardial ischemia during coronary occlusion and
predicts the clinical outcome after PCI (4). The CFI has become the
reference standard for measuring collateral flow in humans, and
patients are categorized as having an adequate or inadequate collateral
supply on the basis of a threshold of 0.25.
Despite the reliance of these indexes on aortic and right atrial
pressure, in the interest of expediency, the latter is rarely measured
in clinical practice and is either ignored or assigned a fixed value.
When Pra is ignored, FFR and CFI become the simplified indexes
Pd/Pa and Pw/Pa, respectively. Although convenient, the errors
introduced by these simplifications have not been systematically
evaluated. This study addressed the hypothesis that failure to
measure Pra when calculating FFR or CFI can result in artifactual
values that cross physiologic dichotomy limits, which determine
clinical care.
Sixty-six patients referred for physiologic evaluation of coronary
stenoses were enrolled in the FFR study. All patients had a lesion
of intermediate severity in a major coronary artery (50% to 75%
diameter stenosis on visual estimation). Patients with angiographi-
cally significant stenoses (75%) in two or more coronary arteries
and those with unstable coronary syndromes were excluded.
Sixty-two patients with single-vessel coronary disease undergo-
ing elective PCI were enrolled in the CFI study. All patients had
stable angina pectoris and/or evidence of reversible ischemia on
noninvasive testing. Patients were excluded if they had undergone
a previous PCI to any artery or had an acute coronary syndrome
within the previous month.
Coronary angiography and PCI were performed via the femoral
route. Lesion severity was characterized by off-line quantitative
coronary angiography. Right atrial pressure was measured with a
6-F multipurpose catheter inserted via the femoral vein. After
calibration, a pressure-sensing guide wire (Pressurewire, Radi
Medical Systems, Uppsala, Sweden) was advanced beyond the
lesion to measure distal coronary pressure. All measurements were
carried out under conditions of maximal hyperemia induced by
intravenous adenosine. In the CFI study, Pw was measured during
balloon occlusion of the lesion.
Both FFR and CFI were recalculated for each measurement
of Pa and Pd, assuming Pra to be 0 or 5, 8, and 10 mm Hg.
Absolute and relative errors introduced by these estimations
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were calculated by comparison with the actual values for FFR
and CFI using a paired, two-tailed Student t test. Using a
dichotomy threshold of 0.75 for FFR and 0.25 for CFI, the
sensitivity and specificity were calculated for both indexes at
each substituted value of Pra; actual values of FFR and CFI
(incorporating measured Pra) were considered the reference
standard in each case. Data are expressed as the mean value 
standard deviation.
In the FFR study, the mean diameter stenosis was 49  16%.
Using a dichotomy threshold of 0.75, 12 functionally significant
stenoses (14% of all lesions) were misclassified as insignificant
when Pra was ignored. Fewer misclassifications occurred when Pra
was estimated to be 5, 8, or 10 mm Hg, but several physiologically
insignificant lesions were erroneously considered severe when right
atrial pressure was assumed to have a fixed value (Fig. 1A). All
misclassifications occurred in lesions with Pd/Pra values between
0.74 and 0.78. The sensitivity of FFR for detecting significant
coronary lesions was reduced to 64% when Pra was ignored.
Substituting a fixed Pra value when calculating FFR increased the
sensitivity of the technique, but specificity decreased with higher
assumed values of Pra (Fig. 1B).
In the CFI study, the CFI was 0.20  0.11 when measured Pra
was included in the calculation and 0.26  0.10 when Pra was
ignored (p  0.001). The mean error in CFI was 57  89%, 21 
53%, 3  52%, and 20  64% when Pra was assumed to be 0,
5, 8, and 10 mm Hg, respectively (Fig. 2). When Pra was ignored,
16% of individuals with insufficient collateral flow to prevent
ischemia on coronary occlusion (CFI 0.25) were erroneously
considered to have an adequate collateral supply (CFI 0.25). Of
the cases, 10% to 12% were misclassified when Pra was assigned a
fixed value, with CFI being increasingly underestimated at higher
substituted values of Pra. The sensitivity of pressure-derived CFI to
detect inadequate collateral supply was reduced to 75% when Pra
was ignored. Substituting values of 5, 8, and 10 mm Hg in the CFI
calculation increased the sensitivity at the expense of specificity,
and no fixed value of Pra significantly improved the accuracy of the
test.
The principal virtue of FFR is its independence of prevailing
hemodynamic conditions, which in turn reflects the incorporation
of mean aortic and right atrial pressures in its calculation. The
original validation of FFR relied on calculations that included
measurement of central venous pressure (1). However, in practice,
right atrial pressure is often assumed to be negligible, and a
simplified ratio of distal coronary to mean aortic pressure is used
instead. Our study demonstrates that using this simplified index or
assuming a fixed Pra value when calculating FFR could result in
artifactual values that lie on opposite sides of the 0.75 dichotomy
limit, which in turn may lead to inappropriate therapy.
It is also noteworthy that these misclassifications occurred in a
population where mean right atrial pressure was 5.5 mm Hg,
which challenges the notion that right atrial pressure should only
be measured in circumstances where it may be pathologically
elevated.
In view of the lower distal coronary pressures encountered
during coronary occlusion, failure to include actual right atrial
pressure would be expected to cause larger errors in calculation of
CFI than FFR. These errors have not been formally quantified
Figure 2. Errors in collateral flow index (CFI) measurements when right
atrial pressure (Pra) is assigned a fixed value. Circles  the absolute error
in CFI for individual measurements when Pra is ignored or assumed to be
fixed at 5, 8, or 10 mm Hg. Solid squares  the mean error for each
estimation of Pra, and error bars show 2 standard deviation (SD) of the
range of errors. Relative errors (mean  2 SD) are shown below each
distribution.
Figure 1. Accuracy of fractional flow reserve (FFR) when right atrial
pressure (Pra) is assigned a fixed value. (A) Sensitivity and specificity of the
technique (compared with true FFR) for detecting significant lesions at
each assumed value of Pra. Solid bars sensitivity; open bars specificity.
(B) Misclassification of lesions for a FFR threshold of 0.75. Solid bars 
clinically important lesions that would be considered insignificant (FFR
overestimated); open bars  physiologically insignificant lesions that
would be considered clinically important (FFR underestimated). Numbers
above bars show absolute number of lesions.
2090 Correspondence JACC Vol. 44, No. 10, 2004
November 16, 2004:2087–98
before, although it has been suggested that assuming a Pra value of
5 mm Hg results in insignificant differences in CFI (5). In
contrast, our findings show that substantial errors occur when right
atrial pressure is assumed to be a fixed value. It is interesting to
note that Seiler et al. (6) found a better correlation between
Doppler- and pressure-derived CFI when a measurement of
central venous pressure was included, as compared with those
calculations where venous pressure was assumed to be 5 mm Hg.
Given that almost one-sixth of patients in our study were assigned
to the wrong CFI category when Pra was assumed to be negligible
or a fixed value, we believe that measurement of right atrial
pressure is imperative when calculating CFI.
The FFR and CFI were derived and validated with the inclusion
of right atrial pressure. Ignoring Pra in everyday practice debases
the fidelity of FFR and may lead to inappropriate therapy in some
cases. Similarly, assuming a fixed arbitrary Pra value leads to
substantial errors in CFI calculations. Therefore, right atrial
pressure should always be measured when calculating these phys-
iologic indexes. If the simplified index Pd/Pa is used, values
between 0.70 and 0.80 mandate recalculation of true FFR, after
measurement of Pra.
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Reticulated Platelets in Acute Coronary Syndrome: A Marker of Platelet Activity
To the Editor: Mean platelet volume (MPV) is elevated in
patients with acute coronary syndrome (ACS) (1) and is used as an
independent predictor of recurrent myocardial infarction and
cardiac death (2). Reticulated platelets (RP) are newly formed
platelets. They are larger in size, have higher granule content, and
selectively bind to thiazole orange dye (TO) that stains ribonucleic
acid and enhances its fluorescence signal (3). We then performed
this study to determine whether RP increase in ACS.
The study population consisted of 13 control subjects, 31
patients with unstable angina (UA), 25 patients with non–ST-
segment elevation myocardial infarction (NSTEMI), and 23 pa-
tients with ST segment elevation myocardial infarction (STEMI).
The Baylor College of Medicine Institutional Review Board
approved the study.
Volumes of 5 cc of blood were drawn before institution of
anticoagulation therapy into collection tubes containing ethyl-
enediaminetetraacetic acid (1.5 mg/ml). Complete blood count
and MPV were performed using an automated analyzer (Sysmex
HST, Kobe, Japan) within 30 min of blood collection. The range
of expected platelet volume in our laboratory is 7.4 to 10.4 fl for a
platelet count of 150 to 400 k/dl.
Reticulated platelets were prepared and measured according to
the previously described methods (4,5). To avoid nonspecific
labeling of RP, RNAse treatment was performed as a control for
measurement of %RP. Platelet-rich plasma was prepared by
centrifugation of collected blood in acid-citrate-dextrose (8.5/1.5,
v/v) at 170 g for 10 min at 22°C. The platelet-rich plasma was fixed
with 1% paraformaldehyde for 15 min divided into two aliquots.
One was incubated with 20 l/ml RNAse (Ambion, Austin,
Texas) for 30 min at 22°C. The second aliquot remained untreated
with RNAse and was used as a blank control. The specimen was
processed as indicated for platelet labeling.
Flow cytometric analysis was performed using a FACScalibur
(Becton Dickinson) flow cytometer. The GPlb-positive cells were
gated in a TO (FL1) versus PE (FL2) dot plot. A positive range
was set for platelets with fluorescence higher than 99% of the
TO-unstained control sample. Agate was set around the platelet
cloud, and 5,000 events were collected. Large TO-positive plate-
lets were assumed to represent RP. To define the frequency of RP,
a line with the same slope as the platelet cluster set to segregate
99% of the normal platelets below the line was established. The
placement of this line is admittedly arbitrary; however, it permits
a consistent and objective approach to the analysis of patients’
samples. In addition, in RNAse experiments, the placement of the
line appears to be appropriate. The true RP count was calculated
by subtraction of the TO-positive platelet count treated with
RNAse from the untreated TO platelet count. Figure 1 demon-
strates a fluorescence histogram of stained platelets with labeled
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